Related Experiment Videos
Use of bronchodilators during non-invasive mechanical ventilation
P Ceriana1, P Navalesi, C Rampulla
1Respiratory Intensive Care Unit, Fondazione S. Maugeri, IRCCS, Istituto Scientifico di Pavia.
Summary
Inhaled bronchodilators are crucial for obstructive airway diseases. This paper reviews aerosol therapy during noninvasive mechanical ventilation, a growing area with limited research.
Area of Science:
- Respiratory Medicine
- Pulmonology
- Critical Care
Background:
- Bronchodilators are key treatments for obstructive airway diseases, with inhalation offering high drug availability and fewer side effects.
- Acute exacerbations can overwhelm respiratory muscles, necessitating ventilatory support to reduce fatigue and improve gas exchange.
- Mechanical ventilation, particularly noninvasive, is effective for hypercapnic ventilatory failure.
Purpose of the Study:
- To analyze the rationale for administering inhaled bronchodilators during noninvasive mechanical ventilation (NIV).
- To assess the feasibility of aerosol therapy in patients receiving NIV.
- To review current data on inhaled drug delivery during NIV.
Main Methods:
- Literature review and analysis of existing data.
- Examination of the physiological principles supporting aerosol delivery during NIV.
- Discussion of clinical evidence and challenges.
Main Results:
- While data on invasive mechanical ventilation aerosol therapy is abundant, research on NIV is scarce.
- Inhaled bronchodilators are often continued or initiated during mechanical ventilation, including NIV.
- The paper aims to consolidate current knowledge on this topic.
Conclusions:
- Further research is needed to optimize aerosol delivery during NIV.
- Understanding the rationale and feasibility is crucial for effective patient management.
- This review highlights the importance of inhaled bronchodilators in NIV settings.